Home

Corona Remedies Ltd 52 Week Low

Image

Corona Remedies Ltd

NSE: CORONA

YEARLOW

₹ 1336.95

Last updated on: Jan 16, 2026

Key Highlights

  • The 52 Week Low of Corona Remedies Ltd is ₹ 1336 as of 16 Jan 26 .

Company Fundamentals for Corona Remedies Ltd

Market Price of Corona Remedies Ltd

1M

1Y

3Y

5Y

Monitoring Corona Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
16 Jan 20261500.7
14 Jan 20261474.25
13 Jan 20261437.45
12 Jan 20261402.7
09 Jan 20261425.6
08 Jan 20261463.85
07 Jan 20261446.9
06 Jan 20261430.35
05 Jan 20261466.5
02 Jan 20261445.7

Asset Value vs Market Value of Corona Remedies Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Corona Remedies Ltd

No data available

* All values are in crore

Historical Net Profit of Corona Remedies Ltd

No data available

* All values are in crore

Corona Remedies Ltd News Hub

Shares of Corona Remedies list in B group

The equity shares of Corona Remedies (Scrip Code: 544644) are listed effective 15 December 2025 and

Read more

15 Dec 25

Corona Remedies Q2 PAT climbs 22% YoY to Rs 52 cr

Profit before tax (PBT) increased 21.67% year on year (YoY) to Rs 69.78 crore in Q2 FY26. Earnings B

Read more

03 Jan 26

Corona Remedies gains as Q2 PAT climbs 22% YoY to Rs 52 cr

Profit before tax (PBT) increased 21.67% year on year (YoY) to Rs 69.78 crore in Q2 FY26. Earnings B

Read more

05 Jan 26

Corona Remedies spurts on market debut

The stock was listed at Rs 1,452, exhibiting a premium of 36.72% to the issue price. So far, the sto

Read more

15 Dec 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of null

Why is it important to track the 52-week low of Corona Remedies Ltd stocks?

Investors should monitor the 52-week low of Corona Remedies Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Corona Remedies Ltd stocks hitting a 52-week low?

Factors leading to Corona Remedies Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Corona Remedies Ltd stocks when they hit a 52-week low?

Buying Corona Remedies Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Corona Remedies Ltd stocks?

Investors should monitor the 52-week low of Corona Remedies Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Corona Remedies Ltd stock at their 52-week low?

An investor can analyze the reasons for the Corona Remedies Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Corona Remedies Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Corona Remedies Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Corona Remedies Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions